28 July 2026
Rosof's appointment underscores Bayer's commitment to accelerating the delivery of innovative medicines and strengthening talent development across Asia Pacific.
Tag: pharmaceutical industry
23 July 2026
The Galen Centre says the US' 100% tariff on imported generic drugs, which will take effect in August 2028, may severely affect Malaysian drug makers exporting to that market. The US is Malaysia's second-biggest export destination for pharmaceuticals.
16 July 2026
MOH warns rising API costs could push up medicine prices and private treatment costs, while squeezing local generic drugmakers and distributors. The government’s drug may also come under pressure.
15 July 2026
MOH refutes Pharmaniaga's claim that the government spent more on originators than generics in 2025, clarifying that MOH spent RM3 billion on generics, comprising 78% of its RM3.86 billion drug budget, while RM850 million (22%) was spent on innovators.
7 July 2026
Pharmaniaga says 59% of the government's pharmaceutical spending in 2025 went to innovators (RM2.1b), compared to 41% on generics (RM1.4b). The government also allocated two-thirds of its budget on imported drugs, be it originators or imported generics.
19 May 2026
Letter
Malaysia’s Blind Spot On Fake Medicines: Why Ancient Deception Still Thrives — Saiman Raj Aruldas
Fake medicines have survived for centuries because human vulnerability has remained constant. Malaysia’s true challenge is not simply defeating counterfeiters, but overcoming the ancient habits that allow them to thrive.
9 April 2026
The MMA wishes to emphasise that the global situation remains uncertain, and we cannot rely solely on the current stability.
2 April 2026
MOH's Pharmaceutical Services Programme is tightening medicine dispensing as global cost pressures rise, saying it's "optimising dispensing practices based on clinical needs" and "reviewing patients' existing medication supply to avoid duplication".
25 March 2026
APHM says private hospitals in Malaysia have yet to face drug supply disruptions, adding that it will monitor any indications of a significant increase in the cost of medicines and medical consumables that may arise during the West Asia conflict.
27 February 2026
Drug makers must notify authorities six months before potential shortages. MOH keeps one to three months of medicine stock and appoints multiple suppliers to reduce supply risks, while monitoring supply and using pool procurement to secure critical drugs.